File Download

There are no files associated with this item.

Supplementary

Conference Paper: Phase I trial of Recombinant Human Arginase 1 (PEG-BCT-100) combined with Capecitabine and Oxaliplatin (PACOX) in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma

TitlePhase I trial of Recombinant Human Arginase 1 (PEG-BCT-100) combined with Capecitabine and Oxaliplatin (PACOX) in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma
Authors
Yau, TCC
Issue Date2017
Citation
Symposium of Pegylated Human Recombinant Arginase in the Treatment of Cancers and other human Disease, Hong Kong, September 2017 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/270643

 

DC FieldValueLanguage
dc.contributor.authorYau, TCC-
dc.date.accessioned2019-06-03T07:13:09Z-
dc.date.available2019-06-03T07:13:09Z-
dc.date.issued2017-
dc.identifier.citationSymposium of Pegylated Human Recombinant Arginase in the Treatment of Cancers and other human Disease, Hong Kong, September 2017-
dc.identifier.urihttp://hdl.handle.net/10722/270643-
dc.languageeng-
dc.relation.ispartofSymposium of Pegylated Human Recombinant Arginase in the Treatment of Cancers and other human Disease, Hong Kong-
dc.titlePhase I trial of Recombinant Human Arginase 1 (PEG-BCT-100) combined with Capecitabine and Oxaliplatin (PACOX) in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma-
dc.typeConference_Paper-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.identifier.hkuros296358-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats